EMF | EMXC | EMF / EMXC | |
Gain YTD | 32.736 | 17.505 | 187% |
Net Assets | 263M | 12.7B | 2% |
Total Expense Ratio | N/A | 0.25 | - |
Turnover | 19.14 | 12.00 | 160% |
Yield | 1.43 | 2.70 | 53% |
Fund Existence | 39 years | 8 years | - |
EMF | EMXC | |
---|---|---|
RSI ODDS (%) | 4 days ago73% | N/A |
Stochastic ODDS (%) | 4 days ago78% | 4 days ago89% |
Momentum ODDS (%) | 4 days ago77% | 4 days ago86% |
MACD ODDS (%) | 4 days ago82% | 4 days ago81% |
TrendWeek ODDS (%) | 4 days ago81% | 4 days ago81% |
TrendMonth ODDS (%) | 4 days ago85% | 4 days ago80% |
Advances ODDS (%) | 4 days ago87% | 4 days ago81% |
Declines ODDS (%) | 7 days ago84% | 7 days ago78% |
BollingerBands ODDS (%) | 4 days ago89% | 4 days ago90% |
Aroon ODDS (%) | 4 days ago86% | 7 days ago82% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FTXH | 28.26 | 0.30 | +1.06% |
First Trust Nasdaq Pharmaceuticals ETF | |||
DXIV | 60.70 | 0.35 | +0.58% |
Dimensional International Vector Eq ETF | |||
EJAN | 32.81 | 0.13 | +0.39% |
Innovator Emerging Mkt Pwr Buff ETF™ Jan | |||
JPC | 8.15 | 0.02 | +0.25% |
Nuveen Preferred & Income Opportunities Fund | |||
QSPT | 30.72 | 0.04 | +0.13% |
FT Vest Nasdaq-100® Buffer ETF Sep |
A.I.dvisor indicates that over the last year, EMXC has been loosely correlated with TEL. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if EMXC jumps, then TEL could also see price increases.
Ticker / NAME | Correlation To EMXC | 1D Price Change % | ||
---|---|---|---|---|
EMXC | 100% | +0.88% | ||
TEL - EMXC | 61% Loosely correlated | +0.10% | ||
OUT - EMXC | 58% Loosely correlated | -0.55% | ||
LTM - EMXC | 56% Loosely correlated | -2.08% | ||
CLS - EMXC | 55% Loosely correlated | +9.64% | ||
INFY - EMXC | 50% Loosely correlated | -1.27% | ||
More |